StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock.
Titan Pharmaceuticals Trading Up 1.7 %
Shares of TTNP stock opened at $7.09 on Tuesday. The company’s fifty day moving average price is $7.36 and its 200-day moving average price is $7.16. The stock has a market cap of $6.45 million, a PE ratio of -0.86 and a beta of 1.33. Titan Pharmaceuticals has a 12 month low of $5.00 and a 12 month high of $16.60.
About Titan Pharmaceuticals
Further Reading
- Five stocks we like better than Titan Pharmaceuticals
- Stock Sentiment Analysis: How it Works
- 3 Stocks Leading the U.S. Agriculture Comeback
- Ride Out The Recession With These Dividend KingsĀ
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Options Trading – Understanding Strike Price
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Titan Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.